Cisplatin combination drugs induce autophagy in HeLa cells and interact with HSA via electrostatic binding affinity. Issue 36 (21st April 2017)
- Record Type:
- Journal Article
- Title:
- Cisplatin combination drugs induce autophagy in HeLa cells and interact with HSA via electrostatic binding affinity. Issue 36 (21st April 2017)
- Main Title:
- Cisplatin combination drugs induce autophagy in HeLa cells and interact with HSA via electrostatic binding affinity
- Authors:
- Chen, Xuerui
Zhang, Li
Ding, Shiping
Lei, Qunfang
Fang, Wenjun - Abstract:
- Abstract : Cisplatin combination drugs induce autophagy in HeLa cells and interact with HSA via electrostatic binding affinity. Abstract : Cisplatin, as a significant chemotherapeutic drug for the treatment of cancers, was combined with rapamycin (RAPA), an autophagy inducer, or 3-methyladenine (3-MA), an autophagy inhibitor, and these cisplatin combination drugs were tested with HeLa cells to explore their specific effects on autophagy by cell viability assay, mitochondria membrane potential (MMP) determination, transmission electron microscopic (TEM) observation, dansylcadaverine (MDC) staining, and western blotting analysis. Results revealed that cisplatin combination drugs enhanced formation of autophagosomes, and morphological and biochemical markers of autophagy in HeLa cells can be clearly determined with the formation of enlarged acidic vesicles and conversion of light chain 3 (LC3) protein. Cisplatin combination drugs induce stronger effects on autophagy than either of the components does. Combination drug-induced autophagy inhibits the growth of HeLa cell in a dose-dependent manner and subsequently sensitizes the cells to apoptosis and cell death. Furthermore, interactions between cisplatin combination drugs and human serum albumin (HSA) were investigated under fluorescence, synchronous fluorescence, and circular dichroism analysis. Results suggest that cisplatin combination drugs can bind to HSA and induce conformation and microenvironmental changes of HSA viaAbstract : Cisplatin combination drugs induce autophagy in HeLa cells and interact with HSA via electrostatic binding affinity. Abstract : Cisplatin, as a significant chemotherapeutic drug for the treatment of cancers, was combined with rapamycin (RAPA), an autophagy inducer, or 3-methyladenine (3-MA), an autophagy inhibitor, and these cisplatin combination drugs were tested with HeLa cells to explore their specific effects on autophagy by cell viability assay, mitochondria membrane potential (MMP) determination, transmission electron microscopic (TEM) observation, dansylcadaverine (MDC) staining, and western blotting analysis. Results revealed that cisplatin combination drugs enhanced formation of autophagosomes, and morphological and biochemical markers of autophagy in HeLa cells can be clearly determined with the formation of enlarged acidic vesicles and conversion of light chain 3 (LC3) protein. Cisplatin combination drugs induce stronger effects on autophagy than either of the components does. Combination drug-induced autophagy inhibits the growth of HeLa cell in a dose-dependent manner and subsequently sensitizes the cells to apoptosis and cell death. Furthermore, interactions between cisplatin combination drugs and human serum albumin (HSA) were investigated under fluorescence, synchronous fluorescence, and circular dichroism analysis. Results suggest that cisplatin combination drugs can bind to HSA and induce conformation and microenvironmental changes of HSA via electrostatic binding affinity. These investigations can provide useful and fundamental information, which could be used in cytotoxic chemotherapy to dramatically increase efficacy in pharmaceutical and biotechnology fields. … (more)
- Is Part Of:
- RSC advances. Volume 7:Issue 36(2017)
- Journal:
- RSC advances
- Issue:
- Volume 7:Issue 36(2017)
- Issue Display:
- Volume 7, Issue 36 (2017)
- Year:
- 2017
- Volume:
- 7
- Issue:
- 36
- Issue Sort Value:
- 2017-0007-0036-0000
- Page Start:
- 22270
- Page End:
- 22279
- Publication Date:
- 2017-04-21
- Subjects:
- Chemistry -- Periodicals
540.5 - Journal URLs:
- http://pubs.rsc.org/en/Journals/JournalIssues/RA ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/c7ra00056a ↗
- Languages:
- English
- ISSNs:
- 2046-2069
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8036.750300
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 370.xml